Genetic characteristics analysis of influenza A(H1N1) virus in Jiaxing, China, in the postepidemic era. [PDF]
Song Y +9 more
europepmc +1 more source
Expansion of influenza A(H1N1)pdm09 NA:S247N viruses with reduced susceptibility to oseltamivir, Catalonia, Spain, and in Europe, July to October 2025. [PDF]
Saubi N +20 more
europepmc +1 more source
Triple Viral Respiratory Co-Infection With Respiratory Syncytial Virus (RSV), Human Metapneumovirus (HMPV), and Influenza A (H1N1) Leading to Acute Respiratory Distress Syndrome (ARDS) in an Infant: A Case Report. [PDF]
Hatimi M +8 more
europepmc +1 more source
Role of the Chaperone Protein 14-3-3η in Regulation of the Infection Dynamics of the Influenza A (H1N1) Virus. [PDF]
Chatterjee D +3 more
europepmc +1 more source
Influenza a(H1N1) virus infection impairs syncytiotrophoblast functions by promoting ferroptosis through the TNF-α/ISG15/EGR1 axis. [PDF]
Zhao Y, Wang Y, Huang K, Wang F, Wang Y.
europepmc +1 more source
TMPRSS2 inhibitors with broad-spectrum efficacy against SARS-CoV-2 (JN.1) and influenza A (H1N1) viruses protect mice from influenza A infection. [PDF]
Presley L +22 more
europepmc +1 more source
Seroprevalence of influenza A H1N1 and influenza D viruses in ruminants in Qatar. [PDF]
Zedan HT +3 more
europepmc +1 more source
Influenza A(H1N1)pdm09 Virus with Reduced Susceptibility to Baloxavir, Japan, 2024. [PDF]
Takashita E +17 more
europepmc +1 more source
Vaccine Effectiveness Against Influenza A(H1N1), A(H3N2), and B-Associated Hospitalizations, United States, 1 September 2023 to 31 May 2024. [PDF]
Lewis NM +46 more
europepmc +1 more source

